Shukra Pharmaceuticals Share Price

    37.23
    +0.73 (2.00%)
    SHUKRAPHAR • 17 Oct, 2025 | 03:29 PM
    Buy

    1Y Annualised Return

    282.55%

    3Y Annualised Return

    185.46%

    5Y Annualised Return

    158.66%

    10Y Annualised Return

    56.87%

    The current prices are delayed, login or Open Demat Account for live prices.

    Shukra Pharmaceuticals Stock Performance

    1W Return10.34
    1Y Return412.81
    Today's Low37.23
    Prev. Close36.50
    Mkt Cap (Cr.)1,630.23
    1M Return23.93
    3Y Return3,379.44
    52-Week High37.23
    Open37.23
    PE Ratio161.87
    6M Return90.92
    Today's High37.23
    52-Week Low5.75
    Face Value1

    Shukra Pharmaceuticals Company background

    Founded in: 1993
    Managing director: Dakshesh Shah
    Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314, the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Reorganization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 December, 2013.The Company has achieved WHOGMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025.

    Shukra Pharmaceuticals Share Price Today


    As of 19 Oct 2025, Shukra Pharmaceuticals share price is ₹37.2. The stock opened at ₹37.2 and had closed at ₹36.5 the previous day. During today’s trading session, Shukra Pharmaceuticals share price moved between ₹37.23 and ₹37.23, with an average price for the day of ₹37.23. Over the last 52 weeks, the stock has recorded a low of ₹5.75 and a high of ₹37.23. In terms of performance, Shukra Pharmaceuticals share price has increased by 90.9% over the past six months and has increased by 282.55% over the last year.
    Read More
    Shukra Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹3,00,000
    Monthly SIP of 5,000 would have become 7,36,43,349 in 5 years with a gain of 7,33,43,349 (+24447.78%)
    View details of Market Depth

    Shukra Pharmaceuticals Fundamental

    Market Cap (in crs)

    1,630.23

    Face Value

    1

    Turnover (in lacs)

    20.30

    Key Metrics

    Qtr Change %
    New 52W High today
    69.2
    Dividend yield 1yr %
    0.03

    Shukra Pharmaceuticals Shareholding Pattern

    Promoter
    51%
    Domestic Institutions
    0.1%
    Public
    48.9%
    Promoter
    51%
    Domestic Institutions
    0.1%
    Public
    48.9%
    Promoter
    51%
    Domestic Institutions
    0.1%
    Public
    48.9%
    Promoter
    51%
    Domestic Institutions
    0.1%
    Public
    48.9%
    Promoter
    51%
    Domestic Institutions
    0.1%
    Public
    48.9%
    Promoter
    51%
    Domestic Institutions
    0.1%
    Public
    48.9%

    Shukra Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    37.23
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    36.00
    10Day EMA
    35.10
    12Day EMA
    34.80
    20Day EMA
    33.60
    26Day EMA
    32.70
    50Day EMA
    29.40
    100Day EMA
    25.30
    200Day EMA
    21.00
    5Day SMA
    35.80
    10Day SMA
    34.50
    20Day SMA
    34.10
    30Day SMA
    32.20
    50Day SMA
    28.30
    100Day SMA
    22.60
    150Day SMA
    21.10
    200Day SMA
    21.10
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    54536 Rs
    54536 Rs
    Week Rs
    228979 Rs
    228979 Rs
    Month Rs
    170223 Rs
    170223 Rs
    37.23
    Pivot
    Resistance
    First Resistance
    37.23
    Second Resistance
    37.23
    Third Resistance
    37.23
    Support
    First Support
    37.23
    Second support
    37.23
    Third Support
    37.23
    Relative Strength Index
    77.15
    Money Flow Index
    75.84
    MACD
    2.08
    MACD Signal
    2.12
    Average True Range
    0.68
    Average Directional Index
    48.21
    Rate of Change (21)
    23.93
    Rate of Change (125)
    94.62

    Shukra Pharmaceuticals Latest News

    15 OCT 2025 | Wednesday

    Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    08 OCT 2025 | Wednesday

    Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    08 OCT 2025 | Wednesday

    Shukra Pharmaceuticals Ltd - 524632 - Authorization Received From Meril Healthcare Private Limited For The Project Of ROBOTIC ASSISTED SURGERY SYSTEM FOR ORTHOPEDICS At Directorate General Armed Forces Medical Services And INHS Asvini, Maharashtra.

    View More

    Shukra Pharmaceuticals Share Price FAQs

    You can easily buy Shukra Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Shukra Pharmaceuticals share price is ₹37.23 and ₹5.75 as of 17/10/2025.

    Please be aware that Shukra Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Invest in Shukra Pharmaceuticals
    +91 -

    Popular Stocks
    331.65
    -4.40 (-1.31%)
    172.22
    -1.78 (-1.02%)
    342.65
    -5.20 (-1.49%)
    412.80
    +1.00 (+0.24%)
    397.80
    -1.20 (-0.30%)
    Top Gainers
    2,507.80
    +98.10 (+4.07%)
    3,647.20
    +86.40 (+2.43%)
    1,202.70
    +27.40 (+2.33%)
    2,012.00
    +44.60 (+2.27%)
    412.15
    +7.00 (+1.73%)
    Top Losers
    240.90
    -12.91 (-5.09%)
    1,441.10
    -30.40 (-2.07%)
    1,486.20
    -28.80 (-1.90%)
    342.65
    -5.20 (-1.49%)
    1,447.60
    -16.20 (-1.11%)
    Invest in Shukra Pharmaceuticals
    +91 -